Elanco Animal Health Incorporated Common Stock (ELAN)
Stock · NYSE · Health Care
$24.11as of 8/28/2026
Price chart
Open in TradingViewActive signals
About ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 9,400
- Website
- www.elanco.com/
Fundamentals
- 1-day range
- $24$24.76
- Market cap
- $12.85B
- P/E (trailing)
- —
- P/E (forward)
- 18.84
- EPS (trailing)
- $-0.42
- Dividend yield
- —
- Beta
- 1.72
- Avg. volume
- 6.07M
How Elanco Animal Health Incorporated Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub
Forecasts
14 analyst ratings
Elanco Animal Health Incorporated Common Stock Competitors
Chosen by industry and closest market cap.
- ELANElanco Animal Health Incorporated Common Stock$24.12▼ 1.51%Market cap $12.85BP/E —$17.11$27.98
- MDGLMadrigal Pharmaceuticals Inc. Common Stock$534.12▼ 1.76%Market cap $11.14BP/E —$393.61$615
- AXSMAxsome Therapeutics Inc. Common Stock$199.01▼ 3.52%Market cap $10.86BP/E —$112.9$260.19
- ABVXAbivax SA American Depositary Shares$113.41▼ 0.78%Market cap $10.74BP/E —$60.45$139
- ASNDAscendis Pharma A/S Ordinary Share$248.06▼ 0.52%Market cap $15.09BP/E 26.94$186.05$282.15
- SMMTSummit Therapeutics Inc. Common Stock$13.71▼ 4.33%Market cap $10.41BP/E —$12.07$29.23
- BBIOBridgeBio Pharma Inc. Common Stock$76.62▼ 2.62%Market cap $15.65BP/E —$48.78$93.42
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ELAN Elanco Animal Health Incorporated Common Stock | $12.85B | — | $24.12 | ▼ 1.51% | $17.11$27.98 |
| MDGL Madrigal Pharmaceuticals Inc. Common Stock | $11.14B | — | $534.12 | ▼ 1.76% | $393.61$615 |
| AXSM Axsome Therapeutics Inc. Common Stock | $10.86B | — | $199.01 | ▼ 3.52% | $112.9$260.19 |
| ABVX Abivax SA American Depositary Shares | $10.74B | — | $113.41 | ▼ 0.78% | $60.45$139 |
| ASND Ascendis Pharma A/S Ordinary Share | $15.09B | 26.94 | $248.06 | ▼ 0.52% | $186.05$282.15 |
| SMMT Summit Therapeutics Inc. Common Stock | $10.41B | — | $13.71 | ▼ 4.33% | $12.07$29.23 |
| BBIO BridgeBio Pharma Inc. Common Stock | $15.65B | — | $76.62 | ▼ 2.62% | $48.78$93.42 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Elanco Animal Health Announces On-Time Completion Of 25K-Square-Foot Manufacturing Expansion Of Its Elwood, Kansas Manufacturing SiteBenzinga · 8/26/2026
- Elanco Animal Health: New Products To Support GrowthSeekingAlpha · 8/19/2026
- Director's Confidence Visible as Elanco Leader Buys 10,000 SharesYahoo · 8/19/2026
- Netflix, Eli Lilly, Elanco Animal Health And More Stock On CNBC’s ‘Final Trades’Benzinga · 8/19/2026
- From The ETF Professor: NFLX content deal helps SKYY, cloud computing ETF, hit high of the day. NFLX 6.6% of ETF's weightBenzinga · 8/18/2026
- Zoetis: A Solid Long-Term Buy After Harsh DrawdownSeekingAlpha · 8/18/2026
- 1 of Wall Street’s Favorite Stocks on Our Watchlist and 2 We Find RiskyYahoo · 8/17/2026
- 5 Must-Read Analyst Questions From Elanco’s Q2 Earnings CallYahoo · 8/14/2026
- Jim Cramer Says He Feels 'Something Not Well' At Zoetis, Names A Rival As His Pickbenzinga · 6/3/2026
Insider Activity
Insider Actions →- Rajeev A. Modi · August 21, 2026 · Grant62 @ $23.97
- Robert M. VanHimbergen · August 21, 2026 · Grant8 @ $23.97
- Jeffrey N. Simmons · August 21, 2026 · Grant118 @ $23.97
- Michael J. Harrington · August 12, 2026 · Buy5.0K @ $21.82
- Rajeev A. Modi · August 7, 2026 · Grant67 @ $22.12
- Robert M. VanHimbergen · August 7, 2026 · Grant9 @ $22.12
- Robert M. VanHimbergen · August 7, 2026 · Buy4.2K @ $23.08
- Jeffrey N. Simmons · August 7, 2026 · Grant128 @ $22.12
- Paul Herendeen · August 7, 2026 · Buy10.0K @ $23.69
- Rajeev A. Modi · July 24, 2026 · Grant59 @ $24.91
- Robert M. VanHimbergen · July 24, 2026 · Grant8 @ $24.91
- Jeffrey N. Simmons · July 24, 2026 · Grant113 @ $24.91
- Rajeev A. Modi · July 10, 2026 · Grant60 @ $24.82
- Robert M. VanHimbergen · July 10, 2026 · Grant8 @ $24.82
- Jeffrey N. Simmons · July 10, 2026 · Grant114 @ $24.82
Institutional Ownership
March 31, 2026
- Total shares held
- 516.87M
- Total value held
- $11.36B
- Institutional holders
- 504
- Unknown68.94M
- Unknown50.93M
- Unknown47.62M
- Unknown45.84M
- Unknown34.64M
- Unknown24.53M
- Unknown22.34M
- Unknown15.34M
- Unknown13.61M
- Unknown11.19M
See the full, filterable feed with live charts on the MarketWall dashboard.